Ranbaxy has fallen off a cliff over the ban imposed by the US FDA. However, the stock market may have over-reacted to the news and there is an opportunity here to make quick-fire gains
Posts tagged J. B. Chemicals
Check Out Daljeet Kohli’s Latest Pharma Stock Pick: Cadila Healthcare
Daljeet Kohli of IndiaNivesh is obviously buoyed by the success of his earlier two stock picks, Alembic Pharma & J. B. Chem. Both stocks have given hefty returns and are still looking good for more gains. His latest stock pick, Cadila Healthcare, has been an under-performer so far. However, a re-rating is on the cards for Cadila and there will be a 20% gain, says Daljeet confidently
Daljeet Kohli Of IndiaNivesh’s Model Portfolio Of Top Stocks Outperforms
Daljeet Kohli Of IndiaNivesh is well known for his stock picks like Alembic Pharma & J. B. Chem. His Model Portfolio for investors has heavily outperformed the Benchmark Index
Daljeet Kohli’s Stock Pick J. B. Chemicals Is On The Move. Do You Have It In Your Portfolio?
Daljeet Kohli’s stock pick J. B. Chemicals sprinted 7% today. It has given a return of 44% since he recommended it and seems to be headed higher
Sharekhan’s Top Stock Idea: Buy JB Chemicals
Sharekhan recommends buying J. B. Chemicals with a target price of Rs. 189 meaning that there is an upside of 30% + in the stock
ICICI’s 9 Top Quality Techno-Funda Stock Picks For 2014
ICICI Direct has released a report recommending 9 top quality stocks that can be bought by investors from a technical – fundamental perspective
Daljeet Kohli’s Stock Portfolio Picks For 2014
We like to keep an eye on Daljeet Kohli’s stock picks because there is a chance for profit there. Let’s take a look at his stock picks for 2014 and see whether they have the potential to enrich us
Will Daljeet Kohli’s Latest Stock Pick J.B. Chemicals Also Give Multibagger Returns?
Daljeet Kohli of IndiaNivesh shot into stardom when his stock pick Alembic Pharma became a super-duper multibagger. His latest stock pick J.B. Chemicals is based on the same formula of low risk and high returns. Will it live up to the promise and enrich investors?
Recent Comments